Skip to Main Content
California State Board of Pharmacy

CPJE Investigation Update – 10/14/19

The California State Board of Pharmacy (board) is continuing to investigate wide-scale subversion of the California Practice Standards and Jurisprudence Examination for Pharmacists (CPJE). The subversion involves instances of applicants removing and sharing exam questions with other applicants.

In the meantime, all pending CPJE results have been invalidated. The board is working on a solution to allow impacted candidates a limited opportunity to retake the CPJE at no cost. The board expects to release more information about how to retake the exam within a week.

We understand and regret the hardship that invalidating CPJE scores has caused for pharmacist candidates. This has also been a difficult process for the board.

However, as a state consumer protection agency, the board’s priority is to ensure applicants can reliably demonstrate they possess the proper knowledge, training and skill necessary to provide competent pharmacy care for California consumers. We believe this solution enables the board to assist candidates while also meeting its statutory obligation of setting protection of the public as “the highest priority for the California State Board of Pharmacy.” (Business and Professions Code section 4001.1)

Anyone with information relevant to the CPJE investigation is urged to contact the board at (916) 518-3106 or ask.inspector@dca.ca.gov. Information may be reported anonymously.

ASHP Statement Regarding CPJE – Updated 10/1/19

The California State Board of Pharmacy is posting the following statement issued by American Society of Health-System Pharmacists (ASHP) on Oct. 1, 2019. Questions may be directed to ASD@asph.org.

Dear Residency Program Directors and Directors of Pharmacy,

In response to  the California (CA) Practice Standards and Jurisprudence Exam for Pharmacists (CPJE) compromise, the Commission on Credentialing voted to recommend, and the ASHP Board of Directors approved, the following waivers for CA Residency programs.

  1. To grant a temporary waiver to any CA pharmacy resident who passed the North American Pharmacist Licensure Examination (NAPLEX) for the requirement that residents complete 2/3 of their residency as a pharmacist licensed to practice in the program’s jurisdiction until the CA State Board of Pharmacy resolves the California Practice Standards and Jurisprudence Examination for Pharmacists (CPJE) compromise, CPJE results are released, and pharmacy residents are licensed. During the waiver period, no CA or Veterans Affairs (VA) program affected by the CPJE compromise will be sanctioned for not meeting the licensure requirement.

  2. To grant a temporary waiver to any resident who sought initial licensure in CA, passed the NAPLEX, and practices in a VA facility in another state for the requirement that residents complete 2/3 of their residency as a pharmacist licensed to practice in the program’s jurisdiction until the CA State Board of Pharmacy resolves the CPJE compromise, CPJE results are released, and pharmacy residents are licensed. During the waiver period, no VA program affected by the CPJE compromise will be sanctioned for not meeting the licensure requirement.

  3. To grant a temporary waiver to any post-graduate year two (PGY2) pharmacy resident not originally licensed in CA and seeking licensure in CA for the requirement that residents complete 2/3 of their residency as a pharmacist licensed to practice in the program’s jurisdiction until the CA State Board of Pharmacy resolves the CPJE compromise, CPJE results are released, and pharmacy residents are licensed. During the waiver period, no CA or VA program affected by the CPJE compromise will be sanctioned for not meeting the licensure requirement.

The temporary waivers remain in effect until the CPJE compromise is resolved and the COC takes an additional action to rescind the waivers.

Stephen Ford, Pharm.D., BCOP, BCPS
Director, Residency Accreditation
Accreditation Services Office
ASHP

CPJE Investigation Update (Updated 9/27/19)

The California State Board of Pharmacy is continuing to investigate evidence of cheating on the California Practice Standards and Jurisprudence Examination for Pharmacists (CPJE). So far, evidence indicates numerous exam questions were disclosed and therefore compromised. As a result, the Board will continue to withhold the exam results until the investigation is completed.

Although we recognize the difficulty this delay presents for applicants, the Board’s priority is to ensure applicants can reliably demonstrate they possess the proper knowledge, training and skill necessary to provide competent pharmacy care for consumers.

Anyone with information related to the investigation is urged to contact the Board by filing a complaint at https://www.pharmacy.ca.gov/forms/complaint_form2.pdf or contacting the board directly at (916) 518-3106 or ask.inspector@dca.ca.gov. Information may be reported anonymously.

Board Statement Regarding CPJE

The California State Board of Pharmacy has received credible information indicating the validity and reliability of the California Practice Standards and Jurisprudence Examination for Pharmacists (CPJE) has been compromised. As a result, the board is not releasing the CPJE results until further notice. The board is conducting an investigation into this matter and encourages anyone with any information to contact the board at www.pharmacy.ca.gov/forms/complaint_form2.pdf. We will release more information as we are able to do so.